Mayne Pharma reaches settlement in class action over antitrust probe

SYDNEY: Generic drug maker Mayne Pharma has resolved a shareholder class action centred on disclosures…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In